Mark W. Begor - Feb 11, 2022 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 04:34 PM
Previous filing
Jan 4, 2022
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Award $0 +8.98K +18.2% $0.00 58.3K Feb 11, 2022 Direct F1, F2
holding EFX Common Stock 45.9K Feb 11, 2022 2-Year 2021 GRAT
holding EFX Common Stock 45.9K Feb 11, 2022 4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Award $0 +19.6K $0.00 19.6K Feb 11, 2022 Common Stock 19.6K $247.50 Direct F3
transaction EFX Stock Option/Right to Buy Award $0 +17.5K $0.00 17.5K Feb 11, 2022 Common Stock 17.5K $270.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on December 31, 2025.